The Wave Teaches More

Specialist Annex

A coda to “Calling Them Home”

The preceding interlude traced the autowave through cancer. The pattern does not stop there. The same five elements (excitable medium, communication channel, refractory dynamics, stability criterion, re-excitation over destruction) recur across medical domains that current practice treats as unrelated.

Epilepsy: The Purest Case

A seizure is a cardiac fibrillation of the brain. The cortex is an excitable medium. Neurons propagate electrical autowaves through synaptic connections and astrocytic gap junctions (the same connexin-43 that couples cardiac muscle). In epilepsy, the refractory period shortens. GABA inhibition fails. The excitation wave catches its own tail and the whole region seizes — hypersynchronous activity identical in its dynamics to the spiral re-entry that produces ventricular fibrillation.

Anti-epileptic drugs work by extending the refractory period: pharmacological refractory recalibration. Responsive neurostimulation (RNS), an implanted device that detects pre-seizure activity and delivers targeted stimulation, is defibrillation. It re-excites the inhibitory mechanism at the precise moment and location the seizure begins, preserving the medium rather than suppressing it. The wave is restored, not suppressed. The ατ criterion maps precisely: brain injury increases α and τ; post-traumatic epilepsy emerges months to years later as the product climbs toward 0.368.

Autoimmune Disease: The Mirror

Cancer and autoimmune disease are the same pathology facing opposite directions. Cancer is the immune surveillance autowave being blocked, the tumor creating inexcitable islands. Autoimmune disease is the surveillance autowave losing its refractory calibration, firing against self-tissue that should be inexcitable to it. One is insufficient excitation. The other is insufficient refraction. Same autowave. Mirror failures.

The proof is clinical: checkpoint immunotherapy’s most common serious side effect is autoimmune disease. Unblock the wave too much and it overshoots. Treatment for one is the pathology of the other. Immune tolerance is trust. The body teaches its immune system what “self” looks like, and the immune system agrees not to attack. When the communication channel degrades, the trust breaks down.

Central sensitization is pain autowave fibrillation — the nociceptive wave re-entering tissue whose refractory period has shortened, allodynia as the pain system’s equivalent of autoimmunity.

The autowave lens captures refractory calibration failure: the immune system firing when it should rest. A companion section, “The Body Knows Its Own Coordination Class,” examines a deeper question: what the immune system is actually firing at. If coordination-class incoherence within the body’s own signaling (neural topology encoding one coordination class, hormonal program encoding another) degrades the immune system’s self-model, the refractory failure may be downstream of a discrimination failure. See the companion annex for the full argument, empirical validation, and therapeutic implications.

Neurodegeneration: The Dark Autowave

Prion-like protein misfolding (tau in Alzheimer’s, alpha-synuclein in Parkinson’s) propagates as a dark autowave: a self-sustaining wave of pathological template conversion. It draws substrate from the medium, regenerates at every point, and follows the brain’s connectome in a predictable spatial pattern. Braak staging documents the wave. Multiple groups now model this propagation using Fisher-KPP equations on brain graphs — reaction-diffusion autowaves producing traveling wavefronts whose spatial pattern matches Braak staging.

Simultaneously, the brain’s regulatory medium degrades. [Inference] Neuroinflammation may constitute immune fibrillation in the dynamical-systems sense: an excitable cell population that has lost refractory discipline, firing continuously without completing the activation-recovery cycle. The ατ criterion: α climbs through decades of neuroinflammation and protein noise; τ climbs through synaptic loss and astrocytic uncoupling. The clinical trajectory is the paradigmatic phase transition: amyloid detectable fifteen to twenty years before symptoms, apparent stability, then sudden decline when the product crosses the threshold.

This explains why amyloid-clearing trials keep failing. Removing plaques addresses neither α nor τ. The ατ product remains above threshold. Gap junction modulators restoring astrocytic coupling would address τ directly: INI-0602, a connexin hemichannel blocker, protects dopaminergic neurons in Parkinson’s models and halts progression in ALS and Alzheimer’s mouse models.

A related observation from oncology. Every tumor boundary where immune coordination halts carries a thermodynamic shadow that standard calorimetry does not detect. In 1989, V.E. Orel documented triboluminescence from osseous tissue, soft tissue surfaces, and blood circulation. In 1993, he proposed that DNA triboluminescence might stimulate tumor cell growth. His work has effectively disappeared from the literature. The physics community has since confirmed every mechanism Orel invoked. The systematic investigation he implied has still not been conducted. [Prediction]

A specific prediction follows for neurodegeneration. Misfolded protein aggregates are mechanically stiffer than native protein. At every boundary between stiff aggregate and compliant tissue, constant mechanical cycling produces micro-strain at a phase boundary: precisely the condition under which triboemission occurs in materials science. If triboemission operates at these boundaries, it would produce UV photons energetic enough to cause protein crosslinking and generate reactive oxygen species, creating a mechanically mediated positive feedback loop at the wavefront of the dark autowave. [Prediction]

The therapeutic implication is the same in every case: re-excitation is more stable than destruction. Restore the medium. Recalibrate the refractory period. Reduce the friction. Speed the regulatory signal. Let the autowave do what autowaves do.

The cells know how to coordinate. They always did. They need only to hear the signal.

(The extended treatment, covering gut dysbiosis, wound healing, chronic pain, triboemission physics, and the seven-pathology convergence, appears in the online annex.)